EMEA-002016-PIP04-20 - paediatric investigation plan
Alpelisib
PIPHuman
Novartis Europharm Limited
E-mail: paediatric.enquiries@novartis.com
Tel. +41 6132 46715
P/0122/2021: EMA decision of 17 March 2021 on the granting of a product specific waiver for alpelisib (Piqray), (EMEA-002016-PIP04-20)